In this study, we investigated the involvement of caspases in TGFb-induced apoptosis in human B cells. Our results show that TGFb-mediated nuclear fragmentation, observed in the Epstein ± Barr virus-negative Burkitt's Lymphoma cell line BL41, was abolished in the presence of the tripeptide caspase inhibitor ZVAD-fmk or the speci®c caspase-3 inhibitor DEVD-fmk. Other apoptotic manifestations such as cell shrinkage, surface phosphatidylserine expression and chromatin condensation were strongly inhibited by ZVAD-fmk but only partially by DEVD-fmk. This suggests that other caspases in addition to caspase-3 control these apoptotis-associated features. Speci®c activation of caspase-3 during TGFbinduced apoptosis was demonstrated by the DEVD-fmksensitive expression of the active p17 subunit of caspase-3 and by in vivo cleavage of PARP. In addition, TGFb treatment of BL41 promoted the expression of both dephosphorylated and truncated forms of the retinoblastoma protein. Inhibition of caspase-3 activity abolished both nuclear fragmentation and expression of the truncated retinoblastoma protein, without modifying the G1 cell cycle arrest induced by TGFb. Our data thus demonstrate that TGFb-induced apoptosis of lymphoma B lymphocytes is dependent on caspase activation and involves caspase-dependent cleavage of the retinoblastoma protein.
Introduction
B Lymphocyte activation is a complex process that may facilitate both proliferation and cell death in response to extra cellular stimuli. Among these signals, TGFb plays a pivotal role in that, in addition to regulation of IgA isotype switching, it can mediate both cell cycle arrest and apoptosis in B cells (Chaouchi et al., 1995; Coman et al., 1989; Kehrl et al., 1986; Lomo et al., 1995) . Our knowledge of the mechanisms of TGFb-induced apoptosis is still poor and results essentially from studies on hepatic cells (Chen and Chang, 1997; Choi et al., 1998; Chuang et al., 1994; Fan et al., 1996; Inayat-Hussain et al., 1997) . Apoptosis is an active energy-dependent process which is characterized by morphological changes including loss of cell volume, plasma membrane blebbing and cell shrinkage, expression of phosphatidylserine on the outer lea¯et of the cell membrane, chromatin condensation, DNA fragmentation into oligo-nucleosomesized fragments and nuclear fragmentation (Cohen et al., 1992) . There is growing evidence indicating that members of the ICE/CED-3 protease family play key roles in the execution phase of apoptosis (Cohen, 1997; Henkart, 1996; Salvesen and Dixit, 1997) . These cysteine-related proteases, named caspases, are synthesized as inactive proenzymes which are activated following cleavage at speci®c aspartate cleavage sites (Alnemri, 1997) . Some caspases may activate other members of the family and ®nal activation may also result from autoprocessing as reported for caspase-3 (Fernandes- Alnemri et al., 1996; Martin et al., 1996) . The importance of caspases has been demonstrated in dierent systems. Overexpression of caspases promotes apoptosis and deletions or mutations of CED-3 result in protection from normal apoptosis during C. elegans development (Ellis and Horvitz, 1986; Hengartner et al., 1992; Miura et al., 1993) . Moreover, inactivation of caspases by either the cowpox virus protein CrmA or peptide methyl ketones, which bind to the active-site cysteine of caspases prevent apoptosis (Patel et al., 1996; Villa et al., 1997) . Activation of the caspase cascade leads to changes in the plasma-membrane, the mitochondria and the nucleus (Kroemer, 1997) . Among the family of ten or more dierent caspases already described, dierent reports indicate that caspase-3 is a major eector of apoptosis (Anel et al., 1997; Kuida et al., 1996; Ohta et al., 1997) . In addition to well characterized substrates for caspase-3 such as the poly (ADP-Ribose) Polymerase (PARP), novel substrates for caspase-3 including bcl-2, PKC, IkB and retinoblastoma protein (Rb) were recently identi®ed extending the ®eld of activity of this caspase (Barkett et al., 1997; Cheng et al., 1997; Datta et al., 1997; Fattman et al., 1997; Ghayur et al., 1996; Janicke et al., 1996; Tan et al., 1997; Tewari et al., 1995) .
Human Rb has a caspase consensus site, DEADG, at position 883 ± 887 in the amino acid sequence. This site is conserved in the mouse, chicken and xenopus Rb and cleavage of Rb at this site, resulting in the removal of a 5 kDa C terminal fragment, has been observed during apoptosis induced by various stimuli including Fas and TNFa Janicke et al., 1996; Tan et al., 1997) . Tan et al. reported that production of a cleavage resistant Rb, mutated at the consensus DEADG site, antagonized TNFa-induced but not Fasmediated apoptosis, suggesting that caspase-mediated cleavage of the Rb protein is involved in the apoptotic process (Tan et al., 1997) . In addition to the DEADG site, there are other putative sites for caspase cleavage in the sequence of Rb and Fattman et al. (1997) have reported a caspase-dependent cleavage of Rb into 48 and 68 kDa fragments during apoptosis of HL-60 cells activated with anti-cancer agents. Since Rb is an important regulator of cell proliferation Weinberg, 1995) and since we have previously reported that TGFb-mediated human B lymphocyte apoptosis was associated with cell cycle arrest (Chaouchi et al., 1995) we further wondered whether caspase-mediated Rb modi®cations could also be associated with the apoptotic properties of TGFb in B lymphocytes. We therefore investigated the capacity of caspases to regulate TGFb-induced B cell apoptosis and verify whether during this apoptotic process, Rb is sensitive to caspase-mediated proteolytic activity in vivo.
We found that TGFb-mediated apoptosis in the Burkitt's lymphoma BL41 cells is dependent on caspase activation. Speci®c inhibition of the caspase-3 activity abrogated both TGFb-induced nuclear fragmentation and expression of a truncated form of Rb. TGFbdependent G1 cell cycle arrest was not dependent on caspase activity. These data suggest that TGFbinduced apoptosis of lymphoma B lymphocytes is dependent on caspase activation and is speci®cally associated with caspase-dependent cleavage of Rb.
Results
TGFb-induced apoptosis in BL41 cells is prevented by the caspase inhibitor ZVAD-fmk In order to investigate the involvement of caspases in TGFb-induced apoptosis in the Burkitt lymphoma B cell line BL41, we ®rst determined the eect of a largespectrum inhibitor of the caspase family ZVAD-fmk on various features of TGFb-mediated apoptosis including non-nuclear and nuclear events. TGFb induced cell shrinkage (60% vs 4% in control cells) as assessed by cell dot-blot light scatter pro®les by¯ow cytometry ( Figure 1a ). This cell shrinkage was abolished by the presence of 100 mM of the irreversible permeable inhibitor ZVAD-fmk (Figure 1a) . Similarly, TGFbinduced phosphatidylserine expression on the outer lea¯et of the cells (78% vs 16% in control cells) was prevented by ZVAD-fmk (Figure 1b) . We next investigated whether ZVAD-fmk also inhibited nuclear manifestations of TGFb-mediated apoptosis. ZVADfmk signi®cantly inhibited the increase in chromatin condensation triggered by TGFb (45% of hypodiploid nuclei in the presence of TGFb vs 2% from cells which were pretreated with the caspase inhibitor) (Figure 1c) . Finally, we also observed that ZVAD-fmk also prevented nuclear fragmentation characterized by the appearance of nuclear bodies (70% of fragmented nuclei in the presence of TGFb vs 2 and 3% in control and ZVAD-fmk pretreated cells respectively) ( Figure  1d ) as well as DNA fragmentation characterized by the classical ladder pattern of DNA (data not shown). In control experiments, we veri®ed that the DMSO concentrations present in the preparations of ZVADfmk did not modify the amount of TGFb-mediated apoptosis (data not shown). Moreover, TGF-mediated cell death (quanti®ed by microscopic counting of viable cells excluding Trypan blue) was also prevented in the presence of ZVAD-fmk (98% of viable cells as compared to 32% in the absence of ZVAD-fmk) (Table 1) . Thus, these results showed that TGFbinduced apoptosis of human B lymphocytes is dependent on protease activation of the caspase family.
Apoptosis triggered by TGFb is associated with activation of caspase-2 and caspase-3, and cleavage of PARP We next identi®ed which members of the caspase family were activated by TGFb in BL41 cells. For this, we took advantage of the general property of the caspase family as being synthesized as proforms, which are proteolytically cleaved and activated during apoptosis. It is therefore possible to visualize both the inactive proform and the active cleaved fragment(s) by Western blotting. As shown in Figure 2a , production of the 48 kDa proform of caspase-2 was diminished upon TGFb activation, and this was associated with the production of the active fragment of 16 kDa after 24 h of TGFb activation. The p16 subunit was lost after 48 h of stimulation, suggesting that caspase-2 activation by TGFb is transient. We next analysed the expression of caspase-3 (Figure 2b ). The membrane used in Figure 2a was stripped and rehybridized with an antibody speci®c for caspase-3. Caspase-3 p17 and p19 subunits were detected by Western blotting after 24 h of stimulation with TGFb ( Figure 2b ). The amount of the active p17 subunit was maximal 48 h after activation with TGFb. The p19 fragment was present after 24 h and the amount decreased after 48 h of stimulation. These results were in accordance with a previous report showing that the p17 fragment was derived from p19 (Martin et al., 1996) . In order to verify that caspase-3 was activated in vivo by TGFb, we next investigated whether the caspase-3 substrate PARP was cleaved in vivo in BL41 cells activated with TGFb. Cleavage of PARP in TGFb-treated BL41 cells was followed by Western blotting using an anti-PARP antibody capable of detecting both the uncleaved 110 kDa molecule and the apoptotic fragment of 83 kDa. As shown in Figure  2c , PARP was cleaved in cells activated with TGFb and the kinetics of this cleavage was comparable to the kinetic of the appearance of the active subunit p17 of caspase-3. We next used a cell permeable¯uorogenic caspase-3 like substrate containing the sequence GDEVDG (PhiPhilux G 1 D 2 ) to verify the ability of TGFb to activate caspase-3 in intact BL41 cells ( Figure  3) . No caspase-3 activity was detected in control cells ( Figure 3a : 4% of positive cells). In contrast upon TGFb activation, the PhiPhilux G 1 D 2 caspase-3 substrate was cleaved by 35% cells (Figure 3b ).
TGFb-mediated nuclear fragmentation is abolished by DEVD-fmk, a speci®c inhibitor of caspase-3
To assess the role of caspase-3 during TGFb-induced apoptosis, we next analysed the eect of the speci®c caspase-3 inhibitor DEVD-fmk on several properties of apoptosis as described in Figure 1 . We ®rst determined the concentration of DEVD-fmk necessary to inhibit caspase-3 activity. For this, we studied the inhibition Caspases and TGFb-mediated apoptosis N Schrantz et al by DEVD-fmk of the in vivo autoproteolytic cleavage of caspase-3 from the 19 kDa to 17 kDa form and cleavage of PARP induced by TGFb. As shown in Figure 4a , DEVD-fmk at a ®nal concentration of 100 mM inhibited in vivo caspase-3 activity induced by TGFb since no 17 kDa fragment of caspase-3 was detected whereas the 19 kDa remained in DEVD-fmktreated samples. In addition, the cleavage of PARP was completely blocked by ZVAD-fmk and very substantially reduced by DEVD-fmk. The remaining cleavage of PARP in DEVD pre-treated cells was probably due to caspases other than caspase-3 also being able to Figure 1 TGFb-induced apoptosis in BL41 cells is prevented by the caspase inhibitor ZVAD-fmk. BL41 cells (10 6 /ml) were cultured for 48 h without (7) or in the presence of TGFb (1 ng/ml) alone (TGFb) or with ZVAD-fmk (100 mM) (TGF+ZVAD). Apoptotic cells were scored in various ways. (a) cells shrinkage: cells having relatively high side-scatter (SSC) and low forward-scatter (FSC) properties were enumerated as a percentage of the total population. (b) surface phosphatidylserine expression: Cells were stained with Annexine-V-FITC and apoptotic cells having phosphatidylserine on the outer lea¯et of the cell membrane were quanti®ed. (c) Chromatin condensation. Cell nuclei were stained with PI and the hypodiploid DNA peak corresponding to apoptotic nuclei was quanti®ed. (d) Nuclear and DNA fragmentation. Nuclear DNA of cells was stained with DAPI and subsequently analysed under a¯uorescence microscope. DNA fragments were analysed as described in Materials and methods. The number of apoptotic cells is presented for each group BL41 cells (0.5 10 6 /ml) were cultured for 72 h without (control) or in the presence of TGFb (1 ng/ml) alone or with ZVAD-fmk (100 mM) or the combination of TGFb and ZVAD-fmk. Total number and per cent of viable cells were quanti®ed by counting of trypan blue excluding cells cleave PARP in vivo albeit with a lower eciency (Patel et al., 1996; Woo et al., 1998) . We therefore used this concentration to study the involvement of caspase-3 during TGFb-mediated apoptosis. Nuclear fragmentation was strongly diminished by DEVD-fmk and ZVAD-fmk (85 and 95% inhibition respectively, Figure 4b ). In contrast, other markers of apoptosis including cell shrinkage, surface phosphatidylserine expression and chromatin condensation were partially inhibited (from 40 ± 60% inhibition). A similar pattern was observed in six dierent experiments. Higher DEVD-fmk concentrations did not cause stronger speci®c inhibition (data not shown) suggesting that in addition to caspase-3, other caspases are also involved in the control of cell shrinkage, surface phosphatidylserine expression and chromatin condensation whereas nuclear fragmentation is more directly under the control of caspase-3. We also observed the activation of caspase-2 in TGFb-activated BL41 cells (Figure 2a) . We therefore tested whether the speci®c caspase-2 inhibitor ZVDVAD-fmk aected TGFb-induced apoptosis. At ®nal concentrations up to 100 mM ZVDVADfmk did not speci®cally inhibit any of the various markers of TGFb-mediated apoptosis. Moreover, when ZVDVAD-fmk and DEVD-fmk were mixed, there was no additive eect on the partial DEVD-fmk inhibition on cell shrinkage, surface phosphatidylserine expression or chromatin condensation (data not shown).
Retinoblastoma protein cleavage by caspase-3 is associated with TGFb-induced apoptotic nuclear fragmentation
We next investigated the sensitivity of the retinoblastoma protein (Rb) to caspase-mediated cleavage in our experimental conditions. Indeed, Rb contains a consensus caspase cleavage site, DEADG, at amino acid sequence position 883 ± 887. Cleavage at this site would release a 5 kDa C terminal fragment. Fortyeight hours of stimulation of BL41 cells with TGFb led to the dephosphorylation of Rb (a phenomenon associated with cell growth inhibition) and the production of a faster migrating band similar to the truncated form of Rb (DRb) described in other apoptotic stimulations Janicke et al., 1996; Tan et al., 1997) (Figure 5 : lane 1). Pretreatment of TGFb-activated BL41 cells with ZVAD-fmk (100 mM) prevented both apoptosis (3 vs 70% without inhibitor) and the production of the /ml) were cultured with TGFb (1 ng/ml) and the amounts of proforms and p10 subunit of caspase-2 and p19 and p17 subunits of caspase-3 were analysed after various times of TGFb activation (0, 24, 48 h) by Western blotting. The same membrane was sequentially probed with anti-caspase-2 Ab (a), stripped and reprobed with anti-caspase-3 Ab (b). PARP cleavage was analysed by Western blotting with a speci®c anti-PARP antibody (c). Apoptotic cells were quanti®ed as a percentage of all cells cultured for 48 h with or without TGFb by¯ow cytometric analysis of dot-blot light scatter pro®les (5% of apoptosis in control and 71% in TGFb-stimulated cells) Figure 3 Detection of caspase-3 activity in intact cells activated by TGFb. BL41 cells (10 6 /ml) were cultured for 48 h without stimulation (a) or in the presence of TGFb (1 ng/ml) (b). Cells were then incubated with the¯uorogenic caspase-3 substrate PhiPhilux-G 1 D 2 for 1 h and then analysed by¯uorescence-activated cell sorter truncated form DRb (lane 2). Furthermore, pretreatment of TGFb-activated BL41 cells with DEVD-fmk (100 mM) led to both inhibition of nuclear fragmentation (80% inhibition) and disappearance of the DRb form (lane 4). Thus during TGFb-mediated apoptosis process, Rb is presumably cleaved by caspases and in particular by caspase-3. In addition, we observed that the total amount of Rb was always smaller in TGFbstimulated cells than control BL41 cells whereas the amounts of other proteins such as GAPDH were not modi®ed. In the presence of ZVAD-fmk or DEVD-fmk the decrease in Rb expression was largely prevented suggesting that caspases, including caspase-3, also regulate the level of Rb in TGFb-treated BL41 cells.
TGFb-mediated cell growth arrest is not dependent on caspase activation
As Rb is a key modulator of cell cycle progression and TGFb-mediated apoptosis of Burkitt lymphoma cells is also associated with cell cycle arrest (Chaouchi et al., 1995) , we next examined whether the anti-proliferative activity of TGFb is also under the control of caspases. We analysed by PI staining both hypodiploid nuclei (apoptotic cells) and nuclei from viable non-apoptotic cells and determined the per cent of viable cells in G1, S or G2/M phases after 48 h activation with TGFb in the absence or the presence of caspase inhibitors (Figure 6 ). TGFb triggered both apoptosis (47% of the viable cells vs 4% in control cells) and G1 arrest (90% of the viable cells vs 56% in control cells) ( Figure  6b vs Figure 6a ). In the presence of ZVAD-fmk, apoptosis was inhibited (2%) although the cells were still arrested in G1 (93%) (Figure 6c) . A similar pattern was observed with DEVD-fmk: 92% of viable cells remained arrested in G1 whereas apoptosis was reduced from 47 to 19% (Figure 6d ). Similar Figure 4 TGFb-mediated caspase-3 activation and nuclear fragmentation is abolished by DEVD-fmk, a speci®c inhibitor of caspase-3. BL41 cells (10 6 /ml) were cultured for 48 h the presence of TGFb (1 ng/ml) or TGFb and ZVAD-fmk (100 mM) (ZVAD) or TGFb and DEVD-fmk (100 mM) (DEVD) or without stimulation (7). (a) Cleavage of caspase-3 and PARP was determined by immunoblotting as described for Figure 2. (b) The percentage of apoptotic cells as assessed from cells shrinkage, surface phosphatidylserine expression, chromatin condensation and nuclear fragmentation was determined as described in Figure  1 Figure 5 Retinoblastoma protein cleavage by caspase 3 is associated with TGFb-induced apoptosis. BL41 cells (10 6 /ml) were activated for 48 hours in the presence of TGFb (1 ng/ml) without (TGF) or with ZVAD-fmk (100 mM) (TGF/ZVAD), DEVD-fmk (100 mM) (TGF/DEVD). Control cells were cultured without TGFb (7). Rb levels were analysed by Western blotting. Phosphorylated forms are designated pRb, unphosphorylated form as Rb and the truncated form DRb. The amount of protein loaded in each lane was assessed by rehybridization of the ®lter with a speci®c Ab for human GAPDH. Apoptotic cells were identi®ed as cells expressing nuclear fragmentation conclusions were drawn using a dierent methodology based on counting of total viable cells excluding trypan blue after 72 h of culture in the presence of TGFb and ZVAD-fmk (Table 1) . Thus, in contrast to apoptosis, TGFb-mediated G1 arrest is not dependent on the activation of cysteine proteases of the caspase family.
Discussion
The cysteine proteases of the caspase family are important regulators of the apoptotic process (Cohen, 1997) . This report shows that TGFb-mediated B lymphocyte apoptosis is controlled through caspase activation. We demonstrate that various markers of apoptosis, including both non nuclear events (cell shrinkage, exposure of phosphatidylserine residues on the outer lea¯et of apoptotic cells) and nuclear events (chromatin condensation and DNA degradation as well as nuclei fragmentation), were dependent on caspase activity since all were abolished or greatly reduced when cells were pretreated with the irreversible cell permeable tripeptide ZVAD-fmk which is a broadspectrum inhibitor of caspases.
We observed that at least two dierent caspases were activated by TGFb with dierent kinetics. The amount of the active cleaved form of caspase-2 was maximum after 24 h and it disappeared after 48 h. In contrast, the p17 and p19 forms of caspase-3 were apparent 24 h after stimulation with TGFb and the active p17 form, but not the p19 form, was present after 48 h. This dierent kinetics suggested that TGFb could activate a cascade of dierent caspases similar to that described for Fas-mediated apoptosis (Hirata et al., 1998; Kamada et al., 1997; Susin et al., 1997) . However, we were not able to detect, by Western blotting, expression of either proforms or active proteolytic fragments of caspases-1, 4, 6 or 7 in BL41 cells after 30 min and 48 h of activation by TGFb (data not shown). Additional experiments are in progress to determine whether this apparent non activation of other caspases re¯ects restricted TGFb activity to caspases-2 and 3 in B cells, or simply the shortcoming of the technique.
The exact role of caspase-2 in our experimental conditions is still unclear. Although it has been reported that caspase-3 may be involved in the process of caspase-2 activation (Li et al., 1997) , our kinetic observations suggest that caspase-2 activation was associated with early activation of caspase-3 in TGFb-activated BL41 cells. However, no inhibition of caspase-3 activation and PARP cleavage were observed in the presence of the caspase-2 speci®c inhibitor ZVDVAD-fmk. In addition, this inhibitor, at concentrations up to 100 mM, did not aect any of the various markers of TGFb-induced apoptosis. Recently, Choi et al. (1998) also observed a TGFb-dependent activation of caspase-2 in the FaO rat hepatoma cell line. It is nevertheless dicult to conclude that caspase-2 contributes to TGFb-mediated apoptosis in this cell type, as the inhibition experiments were only performed with ZVAD-fmk and not with a speci®c inhibitor of caspase-2. Thus the role, if any, of caspase-2 during TGFb-mediated apoptosis remains to be demonstrated.
The involvement of caspase-3 is more evident. Activation of caspase-3 is observed from day 1 and the active cleaved p17 form of caspase-3 is predominant after 48 h of stimulation when the apoptosis rate is maximum. This activation is associated with in vivo cleavage of PARP, which is one of the natural substrates of caspase 3, and of the cell permeable caspase-3 like substrate PhiPhilux G 1 D 2 . In addition, this caspase activity is sensitive to the speci®c inhibitor DEVD-fmk, indeed, pretreatment with DEVD-fmk abolished both auto cleavage of caspase-3 from the p19 form to the active p17 fragment and cleavage of PARP. In contrast, in the presence of the broadspectrum inhibitor ZVAD-fmk, caspase-3 was either not cleaved or only a small proportion was cleaved into the p19 form, suggesting that proteases other than caspases-2 and 3 but sensitive to inhibitory eects of ZVAD-fmk, were responsible for caspase-3 proteolysis and activation. This is consistent with caspase-3, alone or in association with other caspases, having a central role in the induction of TGFb-mediated apoptosis. Indeed, whereas ZVAD-fmk completely abolished both nuclear and non nuclear features associated with TGFb-mediated apoptosis, speci®c inhibition of caspase-3 only partially inhibited cell shrinkage, external phosphatidylserine expression and chromatin Figure 6 TGFb-mediated cell growth arrest is not dependent of caspase activation. BL41 cells were activated for 48 h without (a) or with TGFb in the absence (b) or the presence of ZVAD-fmk (100 mM) (c) or DEVD-fmk (100 mM) (d). Flow-cytometric analysis of PI¯uorescence of individual nuclei was used to determine the stage in the cell cycle. The percentages of cells in G 1 , S or G 2 /M phase were determined using the computer program Cell-®t DNA Software. Hypodiploid DNA peak corresponding to apoptotic nuclei was quanti®ed as described in Figure 1 condensation. This partial inhibition indicates that these various markers of apoptosis are under the control of caspase-3 in association with other caspases, the nature of which is currently unknown. In contrast, TGFb-mediated-nuclear fragmentation was reproducibly inhibited to approximately the same extent by ZVAD-fmk and DEVD-fmk. This strongly suggests that the nuclear fragmentation observed during TGFbmediated apoptosis is more directly under the control of caspase-3 as it has been reported in other experimental systems (Janicke et al., 1998; Shiokawa et al., 1997; Toyoshima et al., 1997; Woo et al., 1998) .
The nature of the substrates of the caspases activated with TGFb in our experimental conditions remained to be characterized. Since TGFb-mediated apoptosis in BL41 cells is associated to cell cycle arrest (Chaouchi et al., 1995; and Figure 6 ), we next determined the capacity of caspases to process molecules involved in the control of the cell cycle. The retinoblastoma protein was a major candidate for several reasons. Rb contains at least one putative site for caspase cleavage and this site (DEADG) is similar to the caspase-3 cleavage site in PARP (DEVDG). Cleavage at this site would release a 5 kDa C-terminal fragment Janicke et al., 1996; Tan et al., 1997) . We investigated whether TGFb induced the appearance of such a cleaved form of Rb in BL41 cells. Indeed, following apoptotic stimulation by TGFb, we observed two faster migrating forms of Rb, presumably the dephosphorylated form and a cleaved form (DRb) corresponding to the C terminally truncated form of Rb. This band (DRb) was not produced in cells pretreated with the caspase inhibitor ZVAD-fmk indicating that it was the product of proteolysis ( Figure 5 ). In addition, when BL41 cells were activated by TGFb in the presence of zVAD-fmk, and arrested in G1 without detectable apoptosis, only the dephosphorylated form of Rb was detected ( Figure  5 ). We veri®ed that caspase-3 was involved in the production of DRb. Indeed the anti-apoptotic dose of the caspase-3 inhibitor DEVD-fmk (100 mM), which prevents TGFb-mediated nuclear fragmentation, blocked the production of DRb. The signi®cance of this Rb cleavage during TGFb-mediated apoptosis is still unclear. Similar Rb proteolysis has been reported in other experimental systems including TNFa-and Fas-mediated apoptosis and is strictly correlated with the induction of apoptosis Janicke et al., 1996; Tan et al., 1997) . Furthermore, Tan et al. (1997) reported that transfection with a gene encoding a noncleavable mutated form of Rb prevented TNFamediated but not Fas-mediated apoptosis. Therefore at least in some experimental conditions caspase-3 cleavage of Rb is a prerequisite for apoptosis. We have attempted similar experiments but due to the very poor rate of transient transfection of our cells targets, no conclusive results were obtained. Nevertheless, since we observed that among the dierent features of apoptosis studied, only nuclear fragmentation was completely abrogated in the presence of the caspase-3 inhibitor DEVD-fmk, we hypothesize that prevention of Rb cleavage should selectively prevent nuclear fragmentation whereas other features would only be marginally aected. We are currently investigating alternative approaches to determine whether or not this caspase-mediated cleavage of Rb is necessary for TGFb-mediated apoptosis in B lymphocytes. The generation of Rb fragments of 48 and 68 kDa, has also been reported during apoptosis in HL-60 cells (An and Dou, 1996) . These fragments are not produced in the presence of DEVD-fmk suggesting that in addition to the cleavage at the site DEADG, Rb is also cleaved by caspases near the middle of the molecule during apoptosis (Fattman et al., 1997) . However this cleavage may be more dependent on the cell type and the apoptotic stimulus since we did not observe these fragments in our experimental conditions.
Another important issue is whether the caspasemediated cleavage of Rb induces the formation of an apoptotic form of Rb or alternatively whether this cleavage in some ways abolishes anti-apoptotic properties expressed by the non-cleaved Rb form. It has recently been reported, at least in two experimental models, that caspase-3-mediated cleavage of bcl-2 and PKCq can lead to cleaved forms of bcl-2 and PKC exhibiting apoptotic activity (Cheng et al., 1997; Ghayur et al., 1996) . Although such a possibility can not be excluded for Rb, it was recently reported that ectopic expression of DRb is not sucient to induce apoptosis (Janicke et al., 1996; Tan et al., 1997) . There is strong evidence that Rb can exert a potent antiapoptotic activity: Rb-de®cient cells are more sensitive to apoptosis than cells expressing Rb (Berry et al., 1996; Clarke et al., 1992; Fan et al., 1996; Jacks et al., 1992; Lee et al., 1992) , and the production of viral oncoproteins such as E1A and E7, which inhibit Rb by binding to the B pocket, enhances susceptibility to apoptosis (Howes et al., 1994; Rao et al., 1992) . In addition to Rb cleavage, TGFb-mediated apoptosis was always associated with a large decrease of total Rb expression consistent with Rb having a protective eect ( Figure 5 ). Furthermore, treatment with ZVAD-fmk prevented both cleavage and decrease in the amount of Rb expression. These ®ndings are consistent with caspase-mediated cleavage of Rb being necessary for further degradation of Rb. This degradation could then result in the loss of the anti-apoptotic activity associated with the non-cleaved form of Rb. Various reports suggest that the anti-apoptotic activity of Rb is preferentially expressed by the unphosphorylated form (Berry et al., 1996; Fan et al., 1996) which is the active form binding various factors including E2F-1 (Chellappan et al., 1991; Kato et al., 1993; Nevins, 1992) . Thus TGFb-mediated accumulation of unphosphorylated Rb may be the ®rst step allowing further ecient caspase-mediated proteolysis of unphosphorylated Rb. Alternatively, cell cycle arrest observed in the presence of ZVAD-fmk is related to ability of the caspase inhibitor to prevent dephosphorylated Rb cleavage. The mechanisms by which Rb may directly exert its anti-apoptotic activities are still poorly understood. It has recently been reported that deregulated expression of Rb binding proteins such as E2F-1 can promote apoptosis (Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 1994) . However, the role of the Rb binding molecules during the TGFb-mediated apoptosis has not yet been elucidated.
In conclusion, we show that TGFb-mediated apoptosis in BL41 cells is dependent on caspase activation. Moreover, caspase-3, or other DEVD-fmk sensitive caspases, is responsible for Rb cleavage observed during TGFb-induced apoptosis. Thus, these data suggest that this capase-mediated cleavage of Rb may be an important step in the apoptotic program triggered by TGFb in human B lymphocytes.
Material and methods

Reagents
Benzyloxycarbonyl -Val -Ala -Asp(OMe) -¯uoromethylketone (ZVAD-fmk) was purchased from Bachem Biochimie SARL (Voisin le Bretonneux, France), benzyloxycarbonylAsp(OMe)-Glu-Val-Asp(OMe)-¯uoromethylketone (DEVDfmk) from Calbiochem (Meudon, France) and benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-¯uoromethylketone (ZVDVAD-fmk) from Enzyme Product System (Livermore, CA, USA). Stock solutions of ZVAD-fmk (100 mM), DEVDfmk (10 mM) and ZVDVAD-fmk (10 mM) were made in DMSO and kept at 7208C. The working dilutions were made up freshly immediately prior to use. Puri®ed porcine TGFb was from R&D (Wiesbaden, Germany).
BL cell line and bioassays
The Burkitt lymphoma cell line BL41, kindly provided by Drs Alan Calender and Gilbert Lenoir (Lyon, France) is negative for the presence of the EBV genome and was cultured in RPMI 1640 Glutamax culture medium (Seromed, Biochrom, Berlin, Germany) supplemented with 1% antibiotics and 10% fetal bovine serum (Gibco, Grand Island, NY, USA) in 24-well¯at-bottomed microtest plates (Falcon, Oxnard, CA, USA). Cells were cultured for 2 days with or without TGFb (1 ng/ml). Cells were recovered at the end of treatment and the percentage of apoptotic cells was determined as described below.
Determination of apoptosis
B cell apoptosis was detected by cytometric analysis of dotblot light scatter pro®les. The cells (10 6 ) were washed in PBS and resuspended in PBS containing paraformaldehyde (1%). Cells were analysed for their dot-blot light scatter pro®le bȳ ow cytometry using a FACScan¯ow cytometer (BectonDickinson, Mountain View, CA, USA). Apoptotic cells which have a relatively high side-scatter and low forwardscatter properties were enumerated as a percentage of the total population.
Hypodiploid DNA was analysed by¯ow-cytometry as previously described (Chaouchi et al., 1995) . Brie¯y, cells (10 6 ) were washed in PBS and resuspended in 1 ml hypotonic uorochrome solution (50 mg ml 71 propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100) (Sigma, St Louis, MO, USA). Samples were placed at room temperature for 1 h before¯ow-cytometry analysis of PI¯uorescence of individual nuclei using a FACScan¯ow cytometer (BectonDickinson) as described elsewhere (Nicoletti et al., 1991) . Debris were excluded from analysis by raising the forward scatter threshold. The DNA content of the intact nuclei was registered on a logarithmic scale. Apoptotic cells were identi®ed as the nuclei having hypodiploid DNA emittinḡ uorescence in channels 10 ± 200 and were enumerated as a percentage of the total population.
For analysis of phosphatidylserine on the outer lea¯et of apoptotic cells, cells (10 6 ) were washed in PBS and resuspended in incubation buer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) and Annexin-V-FITC (Boehringer Mannheim). After 15 min of incubation at 48C, the¯uorescence emitted by cells was analysed by a FACScan ow cytometer (Becton-Dickinson). Apoptotic cells having phosphatidylserine on the outer lea¯et of the cell membrane and positively stained by Annexin V were enumerated as a percentage of the total population.
Nuclear fragmentation was assessed microscopically. Cells were collected, washed with PBS and ®xed for 10 min in PBS containing 4% paraformaldehyde. After centrifugation, cells were resuspended in 5 ml of 1 mg/ml DAPI. Nuclear morphology was then monitored under a¯uorescence microscope (Leica DM RB).
Western blotting analysis
Cells were lysed by incubation for 1 h on ice in lysis buer (50 mM Tris pH 8, 150 mM NaCl, 1% Nonidet P-40, 2 mM Pefablock from interchim (MontlucË on, France), 1 mM ml 71 Aprotinine, 10 mg ml 71 leupeptine, 2 mg ml 71 Pepstatin A and 100 mg ml 71 Saybean Trypsine inhibitor all from Sigma (St Louis, MO, USA). Aliquots of the lysate were centrifuged for 30 min at 13 000 g at 48C and the supernatant assayed for protein concentration (micro-BCA protein assay, Pierce Chemical Co., Rockford IL, USA). Cell lysate proteins (20 mg) were boiled for 5 min in 16sample buer and resolved by 7.5% or 15% SDS ± PAGE. Proteins were then electroblotted onto 0.45 mm pore-size nitrocellulose ®lters, and the ®lters were blocked for 1 h with 5% non-fat milk in PBS, 0.1% Tween-20. The ®lters were then incubated for 1 h at room temperature with anti-caspase 2 mAb SC-625 (2 mg ml
71
; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-caspase-3 mAb (1 mg ml
; polyclonal Rabbit Anti-Caspase-3 antiserum, Pharmingen San Diego, CA, USA) or PARP mAb C2.10) (1 mg ml 71 ); (C2.10 mAb was purchased from Dr Poirier, Quebec, Canada). Blots were washed three times for 10 min with 0.2% Tween 20 in PBS and incubated for 1 h with peroxidase-labeled anti-mouse or anti-rabbit immunoglobulin (1/5000). Blots were developed using an enhanced chemiluminescence detection system (ECL, Amersham Corp, UK).
Detection of caspase-3 activity in intact cells
The cell-permeable¯uorigenic substrate (PhiPhilux G1D2, OncoImmunin, Inc. Kensington, MD, USA) containing the sequence GDEVDG was used to detect caspase-3 like activity in intact cells. Cells cultured for 24 h with or without TGFb (1 ng/ml) were harvested and washed twice with PBS. 10 6 cells were resuspended in 50 ml of substrate solution and incubated for 1 h at 378C in the dark. After incubation, cells were washed and the¯uorescence emission was determined using a FACScan¯ow cytometer (Becton-Dickinson).
Cell cycle analysis
Approximately 10 6 cells were washed in PBS and resuspended in 1 ml hypotonic¯uorochrome solution (50 mg/ml propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100)(Sigma). Samples were stored at room temperature for 1 h before¯ow-cytometric analysis of PI¯uorescence of individual nuclei using a FACScan¯ow cytometer (BectonDickinson). Cell cycle compartments of viable non apoptotic cells including the G 0 /G 1 , S and G 2 /M phases and the percentages of cells in the compartments were determined using the computer program Cell-Quest (Becton-Dickinson).
